1 Min Read
Oct 11 (Reuters) - Sandoz:
* SANDOZ ANNOUNCES GLOBAL RESOLUTION OF BIOSIMILAR ADALIMUMAB PATENT DISPUTES, SECURING PATIENT ACCESS Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.